Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$34,945,488
+$2,007,114 QoQ
Shares Held
601,161
+6.1% QoQ
Ownership
0.404%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#41
of 329 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. PCVX ranks #24 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in PCVX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,945,488 | 601,161 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $32,938,374 | 566,828 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $24,153,781 | 523,489 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $653,978 | 18,156 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $8,485 | 261 | Shares | Defined | 2025-08-13 | |
| 2024-12-31 | $26,691,107 | 326,058 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $57,254,983 | 501,050 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $32,140,076 | 425,640 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $29,082,982 | 425,750 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $24,755,257 | 394,192 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $20,178,240 | 395,807 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $19,797,913 | 396,434 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,882,699 | 76,913 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $10,501 | 219 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||